Invest in IPO
(initial public offering)

Unique opportunity to invest in company shares at offering price before they start trading on the exchange
Invest in IPO
Huadi International Group
HUDI
Anticipated price
$7 - $8

Our main business operation focuses on new products development, manufacturing, marketing and sales of stainless steel seamless pipes, tubes and stainless steel bar.

Time left before the application deadline:
days
hours
minutes
seconds
Contact usCollapse

How to invest in IPO

Find an IPO
Our calendar contains the latest and most relevant information on initial public offerings.
Open MT5 Global account
Thousands of instruments for investing and trading.
Transfer funds to a trading account
Instant deposit and withdrawal in many convenient ways.
Apply for an IPO in the Private Office
Preliminary position will immediately appear in the portfolio.

IPO Calendar

PRPH
ProPhase Labs
Follow-on
Anticipated date
19.01.2021
Сlosing price
$16

We are a diversified medical science and technology company with deep experience with OTC consumer healthcare products and dietary supplements.

FOXWU
FoxWayne Enterprises Acquisition Corp
IPO
Anticipated date
20.01.2021
Anticipated price
$10 - $10

SPAC Offering: This is an initial public offering of our securities. Each unit has an offering price of $10.00 and consists of one share of our Class A common stock and one redeemable warrant.

HUDI
Huadi International Group
IPO
Anticipated date
22.01.2021
Anticipated price
$7 - $8

Our main business operation focuses on new products development, manufacturing, marketing and sales of stainless steel seamless pipes, tubes and stainless steel bar.

PDO
PIMCO Dynamic Income Opportunities Fund
IPO
Anticipated date
27.01.2021
Anticipated price
$20 - $20

Closed End Fund: The Fund seeks current income as a primary objective and capital appreciation as a secondary objective.

Get analytical
overview on IPO

* Required fields

LTRN
Lantern Pharma
Follow-on
Anticipated date
15.01.2021
Сlosing price
$18.2

We are a clinical stage biotechnology company, focused on leveraging artificial intelligence (“A.I.”), machine learning and genomic data to streamline the drug development process and to identify the patients that will benefit from our targeted oncology therapies.

PRVB
Provention Bio
Follow-on
Anticipated date
14.01.2021
Сlosing price
$17.7

We are a clinical stage biopharmaceutical company, focused on the development and commercialization of novel therapeutics and innovative approaches aimed at intercepting and preventing immune-mediated diseases.

HCDI
Harbor Custom Development
Follow-on
Anticipated date
13.01.2021
Сlosing price
$4.35

We are a real estate development company involved in all aspects of the land development cycle including, land acquisition, entitlements, construction of project infrastructure, home building, marketing, sales, and management of various residential projects in Western Washington’s Puget Sound region.

QLI
Qilian International Holding Group
IPO
Anticipated date
12.01.2021
Anticipated price
$5 - $7

We are a pharmaceutical and chemical company based in China that focuses on the development, manufacture, marketing, and sale of licorice products, oxytetracycline products, traditional Chinese medicine derivatives (“TCMD”) product, heparin product, sausage casings, and fertilizers.

BCYPU
Big Cypress Acquisition
IPO
Anticipated date
12.01.2021
Anticipated price
$10 - $10

Big Cypress Acquisition Corp. is a newly organized blank check company formed for the purpose of effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization or similar business combination, which we refer to as our initial business combination, with one or more businesses, which we refer to as target businesses. We have not selected any specific target business and we have not, nor has anyone on our behalf, initiated any substantive discussions, directly or indirectly, with any target business with respect to an initial business combination with our company. While we may pursue a target business in any industry or sector, we intend to focus our search on companies in the life sciences industry.

FRGAP
Franchise Group, Inc.
Follow-on
Anticipated date
12.01.2021
Сlosing price
$25.21

Series A Cumulative Perpetual Preferred Stock: We are a retailer, franchisor operator and acquirer of franchised and franchisable businesses that can be scaled using our operating philosophies. We currently operate four reportable segments: Liberty Tax, Buddy’s, American Freight, and Vitamin Shoppe.

IKT
Inhibikase Therapeutics
IPO
Anticipated date
23.12.2020
Anticipated price
$10 - $12

We are a clinical stage pharmaceutical company developing therapeutics for Parkinson’s Disease, or PD, and related disorders that arise inside and outside of the brain.

CSSEN
Chicken Soup for the Soul Entertainment
Follow-on
Anticipated date
18.12.2020
Сlosing price
$24.93

9.5% notes due 2025

VIRI
Virios Therapeutics
IPO
Anticipated date
17.12.2020
Anticipated price
$9 - $11

We are a development-stage biotechnology company focused on advancing novel antiviral therapies to treat diseases associated with a viral triggered abnormal immune response, such as fibromyalgia (“FM”).

SCPS
Scopus BioPharma
IPO
Anticipated date
16.12.2020
Anticipated price
$5.25 - $5.75

We are a biopharmaceutical company developing transformational therapeutics targeting serious diseases with significant unmet medical needs.

FAQ

;